GreenLight Biosciences Holdings, PBC filed an amended quarterly report (Form 10-Q/A) with the SEC on November 24, 2021, under ticker ENVI, the listing vehicle of Environmental Impact Acquisition Corp, a blank-check company that completed its initial public offering in 2021. The SPAC targeted the life sciences and biotechnology sector, announcing a business combination with GreenLight Biosciences, an RNA medicines company focused on mRNA-based therapeutics and agricultural biotech applications. The 10-Q/A, carrying accession number 0001213900-21-061958, represents an amendment to a previously submitted quarterly disclosure filed during the active de-SPAC transaction period. For complete filing histories, sponsor profiles, and deal timelines on ENVI and thousands of other SPACs, sign up for full data access on SpacDesk.